Position in AZN
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$512,353
-$24,282 QoQ
Shares Held
2,702
-0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#849
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Canopy Partners, LLC holds $13,071,553 across 11 Drug Manufacturers - General names. AZN ranks #8 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
13,071 | $3,319,641 | |
| 2 | LLY |
ELI LILLY & Co
|
1,784 | $2,139,783 | |
| 3 | MRK |
Merck & Co., Inc.
|
13,530 | $1,738,605 | |
| 4 | AMGN |
Amgen Inc
|
4,519 | $1,636,420 | |
| 5 | ABBV |
AbbVie Inc.
|
5,423 | $1,364,643 | |
| 6 | PFE |
Pfizer Inc
|
36,141 | $870,275 | |
| 7 | NVS |
Novartis AG
|
3,458 | $541,937 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
2,702 | $512,353 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $512,353 | 2,702 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $536,635 | 2,721 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||